A Supreme Court judge set to hear a case involving a challenge by Novartis against Section 3d, a controversial provision in India's patent law, has recused himself ? a move that is now expected to require a new judge to hear the case at a later date ...
Michael Pears and Mike Snodin consider the opinion of an Advocate General of the Court of Justice of the EU on granting supplementary protection certificates for combination medicines. In a non-binding opinion issued on 13 July, Advocate General ...
The US Supreme Court in a 6-2 ruling upheld rulings from lower courts that the National Childhood Vaccine Injury Act of 1986 (NCVIA) pre-empts all design-defect claims against manufacturers brought by plaintiffs seeking compensation for injury or ...
Cécile Derycke and Agnès Roman-Amat discuss the implications of a Civil Supreme Court decision on ?defects? and ?causal relationships?. The French Civil Supreme Court (Cour de Cassation) has upheld for the first time a court of appeal judgment ...
Maarten Meulenbelt and Helmut Brokelmann explore the practical implications of the long-awaited ruling. On 6 October, the European Court of Justice handed down its long-awaited judgment in the Spanish ?dual pricing? case regarding GlaxoSmithKline?s ...
Yesterday's raids on the premises of several pharmaceutical companies show that the European competition authorities are serious about taking action against suspected anticompetitive behaviour in the EU generics market. While the fact that the ...
